Project Number T-PEP-20-674740 Agency/Funding Organization Alzheimer's Association|Tau Consortium Funding Year 2020 View Full Project Details for Safe and Effective Delivery of MSUT2 siRNA for treatment of Tauopathy Research Categorization Primary Disease / Condition Multiple Dementias CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator Friedman, Jeff Principal Investigator First Name Jeff Principal Investigator Last Name Friedman Awardee Organization DTX PHARMA, LLC Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PA 2020: T-PEP RFA FY Overall Cost $400,000 Funding Organization Agency/Funding Organization Alzheimer's Association|Tau Consortium Program Official Murtishaw, Andrew asmurtishaw@alz.org
